nodes	percent_of_prediction	percent_of_DWPC	metapath
Amoxapine—DRD1—Signaling Pathways—ABCA4—age related macular degeneration	0.0014	0.0014	CbGpPWpGaD
Amoxapine—GABRA1—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.0014	0.0014	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—RHO—age related macular degeneration	0.0014	0.0014	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—ABCA4—age related macular degeneration	0.00138	0.00138	CbGpPWpGaD
Amoxapine—HTR2B—GPCR ligand binding—C3—age related macular degeneration	0.00138	0.00138	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—RHO—age related macular degeneration	0.00138	0.00138	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—RHO—age related macular degeneration	0.00136	0.00136	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—RDH8—age related macular degeneration	0.00135	0.00135	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—TGFBR1—age related macular degeneration	0.00134	0.00134	CbGpPWpGaD
Amoxapine—DRD1—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00134	0.00134	CbGpPWpGaD
Amoxapine—DRD3—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00132	0.00132	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—RPE65—age related macular degeneration	0.00131	0.00131	CbGpPWpGaD
Amoxapine—HRH4—Signaling by GPCR—C3—age related macular degeneration	0.00131	0.00131	CbGpPWpGaD
Amoxapine—DRD1—GPCR ligand binding—C3—age related macular degeneration	0.0013	0.0013	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—RHO—age related macular degeneration	0.00129	0.00129	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—RPE65—age related macular degeneration	0.00129	0.00129	CbGpPWpGaD
Amoxapine—DRD2—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00129	0.00129	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—RPE65—age related macular degeneration	0.00129	0.00129	CbGpPWpGaD
Amoxapine—HTR1A—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00129	0.00129	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—RPE65—age related macular degeneration	0.00129	0.00129	CbGpPWpGaD
Amoxapine—DRD3—GPCR ligand binding—C3—age related macular degeneration	0.00128	0.00128	CbGpPWpGaD
Amoxapine—HTR2A—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00127	0.00127	CbGpPWpGaD
Amoxapine—HRH1—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00127	0.00127	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—RPE65—age related macular degeneration	0.00127	0.00127	CbGpPWpGaD
Amoxapine—CHRM1—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00126	0.00126	CbGpPWpGaD
Amoxapine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00124	0.00124	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—RHO—age related macular degeneration	0.00122	0.00122	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—SQSTM1—age related macular degeneration	0.00121	0.00121	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—ABCA4—age related macular degeneration	0.00121	0.00121	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—RHO—age related macular degeneration	0.0012	0.0012	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—ABCA4—age related macular degeneration	0.0012	0.0012	CbGpPWpGaD
Amoxapine—HTR6—GPCR ligand binding—CCL2—age related macular degeneration	0.00118	0.00118	CbGpPWpGaD
Amoxapine—HTR7—GPCR ligand binding—CCL2—age related macular degeneration	0.00118	0.00118	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—RPE65—age related macular degeneration	0.00118	0.00118	CbGpPWpGaD
Amoxapine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00116	0.00116	CbGpPWpGaD
Amoxapine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00115	0.00115	CbGpPWpGaD
Amoxapine—HTR1B—GPCR ligand binding—CCL2—age related macular degeneration	0.00115	0.00115	CbGpPWpGaD
Amoxapine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00114	0.00114	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—SLC16A8—age related macular degeneration	0.00113	0.00113	CbGpPWpGaD
Amoxapine—DRD4—GPCR ligand binding—CCL2—age related macular degeneration	0.00113	0.00113	CbGpPWpGaD
Amoxapine—HTR1A—GPCR ligand binding—C3—age related macular degeneration	0.00112	0.00112	CbGpPWpGaD
Amoxapine—HTR2A—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00111	0.00111	CbGpPWpGaD
Amoxapine—HTR2C—GPCR ligand binding—C3—age related macular degeneration	0.00111	0.00111	CbGpPWpGaD
Amoxapine—HTR2B—GPCR ligand binding—CCL2—age related macular degeneration	0.00108	0.00108	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—ABCA4—age related macular degeneration	0.00106	0.00106	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—RHO—age related macular degeneration	0.00105	0.00105	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—NMNAT1—age related macular degeneration	0.00105	0.00105	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—RHO—age related macular degeneration	0.00104	0.00104	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—ABCA4—age related macular degeneration	0.00104	0.00104	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—ABCA4—age related macular degeneration	0.00104	0.00104	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—ABCA4—age related macular degeneration	0.00104	0.00104	CbGpPWpGaD
Amoxapine—HRH4—Signaling by GPCR—CCL2—age related macular degeneration	0.00102	0.00102	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—ABCA4—age related macular degeneration	0.00102	0.00102	CbGpPWpGaD
Amoxapine—DRD1—GPCR ligand binding—CCL2—age related macular degeneration	0.00102	0.00102	CbGpPWpGaD
Amoxapine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00101	0.00101	CbGpPWpGaD
Amoxapine—DRD3—GPCR ligand binding—CCL2—age related macular degeneration	0.00101	0.00101	CbGpPWpGaD
Amoxapine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.000994	0.000994	CbGpPWpGaD
Amoxapine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.000992	0.000992	CbGpPWpGaD
Amoxapine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.000989	0.000989	CbGpPWpGaD
Amoxapine—DRD2—GPCR ligand binding—C3—age related macular degeneration	0.000983	0.000983	CbGpPWpGaD
Amoxapine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.000973	0.000973	CbGpPWpGaD
Amoxapine—HTR2A—GPCR ligand binding—C3—age related macular degeneration	0.000967	0.000967	CbGpPWpGaD
Amoxapine—HRH1—GPCR ligand binding—C3—age related macular degeneration	0.000965	0.000965	CbGpPWpGaD
Amoxapine—CHRM1—GPCR ligand binding—C3—age related macular degeneration	0.000962	0.000962	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—ABCA4—age related macular degeneration	0.000948	0.000948	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR ligand binding—C3—age related macular degeneration	0.000947	0.000947	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—RHO—age related macular degeneration	0.000922	0.000922	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—ELOVL4—age related macular degeneration	0.000917	0.000917	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—RHO—age related macular degeneration	0.000907	0.000907	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—RHO—age related macular degeneration	0.000905	0.000905	CbGpPWpGaD
Amoxapine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.000904	0.000904	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—RHO—age related macular degeneration	0.000902	0.000902	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—RHO—age related macular degeneration	0.000888	0.000888	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR ligand binding—C3—age related macular degeneration	0.00088	0.00088	CbGpPWpGaD
Amoxapine—HTR1A—GPCR ligand binding—CCL2—age related macular degeneration	0.000876	0.000876	CbGpPWpGaD
Amoxapine—HTR2C—GPCR ligand binding—CCL2—age related macular degeneration	0.000872	0.000872	CbGpPWpGaD
Amoxapine—HTR6—GPCR downstream signaling—C3—age related macular degeneration	0.000855	0.000855	CbGpPWpGaD
Amoxapine—HTR7—GPCR downstream signaling—C3—age related macular degeneration	0.000854	0.000854	CbGpPWpGaD
Amoxapine—HTR1B—GPCR downstream signaling—C3—age related macular degeneration	0.000831	0.000831	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—CD36—age related macular degeneration	0.00083	0.00083	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—RHO—age related macular degeneration	0.000825	0.000825	CbGpPWpGaD
Amoxapine—DRD4—GPCR downstream signaling—C3—age related macular degeneration	0.000817	0.000817	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—TGFBR1—age related macular degeneration	0.000796	0.000796	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—TGFBR1—age related macular degeneration	0.000795	0.000795	CbGpPWpGaD
Amoxapine—HTR2B—GPCR downstream signaling—C3—age related macular degeneration	0.00078	0.00078	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—C3—age related macular degeneration	0.000776	0.000776	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—C3—age related macular degeneration	0.000775	0.000775	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—TGFBR1—age related macular degeneration	0.000774	0.000774	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—C3—age related macular degeneration	0.000771	0.000771	CbGpPWpGaD
Amoxapine—DRD2—GPCR ligand binding—CCL2—age related macular degeneration	0.000769	0.000769	CbGpPWpGaD
Amoxapine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000767	0.000767	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—TGFBR1—age related macular degeneration	0.000761	0.000761	CbGpPWpGaD
Amoxapine—HTR2A—GPCR ligand binding—CCL2—age related macular degeneration	0.000757	0.000757	CbGpPWpGaD
Amoxapine—HRH1—GPCR ligand binding—CCL2—age related macular degeneration	0.000755	0.000755	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—C3—age related macular degeneration	0.000754	0.000754	CbGpPWpGaD
Amoxapine—CHRM1—GPCR ligand binding—CCL2—age related macular degeneration	0.000753	0.000753	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—C3—age related macular degeneration	0.000742	0.000742	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR ligand binding—CCL2—age related macular degeneration	0.000741	0.000741	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—SLC16A8—age related macular degeneration	0.000739	0.000739	CbGpPWpGaD
Amoxapine—DRD1—GPCR downstream signaling—C3—age related macular degeneration	0.000736	0.000736	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—TGFBR1—age related macular degeneration	0.000727	0.000727	CbGpPWpGaD
Amoxapine—DRD3—GPCR downstream signaling—C3—age related macular degeneration	0.000726	0.000726	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—SQSTM1—age related macular degeneration	0.000722	0.000722	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—SQSTM1—age related macular degeneration	0.000721	0.000721	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—APOE—age related macular degeneration	0.000718	0.000718	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—C3—age related macular degeneration	0.000709	0.000709	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—KDR—age related macular degeneration	0.000703	0.000703	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000701	0.000701	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—SQSTM1—age related macular degeneration	0.00069	0.00069	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR ligand binding—CCL2—age related macular degeneration	0.000689	0.000689	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000685	0.000685	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—TGFBR1—age related macular degeneration	0.000676	0.000676	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—C3—age related macular degeneration	0.000668	0.000668	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—C3—age related macular degeneration	0.000659	0.000659	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000659	0.000659	CbGpPWpGaD
Amoxapine—HTR1A—GPCR downstream signaling—C3—age related macular degeneration	0.000633	0.000633	CbGpPWpGaD
Amoxapine—HTR2C—GPCR downstream signaling—C3—age related macular degeneration	0.000629	0.000629	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000621	0.000621	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—SQSTM1—age related macular degeneration	0.000613	0.000613	CbGpPWpGaD
Amoxapine—HTR6—Signaling by GPCR—CCL2—age related macular degeneration	0.000607	0.000607	CbGpPWpGaD
Amoxapine—HTR7—Signaling by GPCR—CCL2—age related macular degeneration	0.000607	0.000607	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—CCL2—age related macular degeneration	0.000603	0.000603	CbGpPWpGaD
Amoxapine—HTR1B—Signaling by GPCR—CCL2—age related macular degeneration	0.00059	0.00059	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000589	0.000589	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—TGFBR1—age related macular degeneration	0.000586	0.000586	CbGpPWpGaD
Amoxapine—DRD4—Signaling by GPCR—CCL2—age related macular degeneration	0.000581	0.000581	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—LIPC—age related macular degeneration	0.000581	0.000581	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—C3—age related macular degeneration	0.000575	0.000575	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—C3—age related macular degeneration	0.000572	0.000572	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—CETP—age related macular degeneration	0.00056	0.00056	CbGpPWpGaD
Amoxapine—DRD2—GPCR downstream signaling—C3—age related macular degeneration	0.000556	0.000556	CbGpPWpGaD
Amoxapine—HTR2B—Signaling by GPCR—CCL2—age related macular degeneration	0.000554	0.000554	CbGpPWpGaD
Amoxapine—HTR2A—GPCR downstream signaling—C3—age related macular degeneration	0.000547	0.000547	CbGpPWpGaD
Amoxapine—HRH1—GPCR downstream signaling—C3—age related macular degeneration	0.000545	0.000545	CbGpPWpGaD
Amoxapine—CHRM1—GPCR downstream signaling—C3—age related macular degeneration	0.000544	0.000544	CbGpPWpGaD
Amoxapine—ADRA1A—GPCR downstream signaling—C3—age related macular degeneration	0.000535	0.000535	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000534	0.000534	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—SQSTM1—age related macular degeneration	0.000532	0.000532	CbGpPWpGaD
Amoxapine—DRD1—Signaling by GPCR—CCL2—age related macular degeneration	0.000523	0.000523	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—TGFBR1—age related macular degeneration	0.000517	0.000517	CbGpPWpGaD
Amoxapine—DRD3—Signaling by GPCR—CCL2—age related macular degeneration	0.000516	0.000516	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000509	0.000509	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000508	0.000508	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000506	0.000506	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—C3—age related macular degeneration	0.000504	0.000504	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000499	0.000499	CbGpPWpGaD
Amoxapine—ADRA2A—GPCR downstream signaling—C3—age related macular degeneration	0.000497	0.000497	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—C3—age related macular degeneration	0.000496	0.000496	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—C3—age related macular degeneration	0.000495	0.000495	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—C3—age related macular degeneration	0.000494	0.000494	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—C3—age related macular degeneration	0.000486	0.000486	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—SQSTM1—age related macular degeneration	0.000469	0.000469	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000463	0.000463	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000462	0.000462	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000461	0.000461	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000459	0.000459	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—C3—age related macular degeneration	0.000459	0.000459	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—C3—age related macular degeneration	0.000458	0.000458	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000452	0.000452	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—C3—age related macular degeneration	0.000452	0.000452	CbGpPWpGaD
Amoxapine—HTR1A—Signaling by GPCR—CCL2—age related macular degeneration	0.00045	0.00045	CbGpPWpGaD
Amoxapine—HTR2C—Signaling by GPCR—CCL2—age related macular degeneration	0.000447	0.000447	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—C3—age related macular degeneration	0.000446	0.000446	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—C3—age related macular degeneration	0.000438	0.000438	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—APOE—age related macular degeneration	0.000427	0.000427	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—APOE—age related macular degeneration	0.000426	0.000426	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—SQSTM1—age related macular degeneration	0.00042	0.00042	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—C3—age related macular degeneration	0.000419	0.000419	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—KDR—age related macular degeneration	0.000418	0.000418	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—KDR—age related macular degeneration	0.000418	0.000418	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—APOE—age related macular degeneration	0.000415	0.000415	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—APOE—age related macular degeneration	0.000408	0.000408	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—KDR—age related macular degeneration	0.000406	0.000406	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—KDR—age related macular degeneration	0.0004	0.0004	CbGpPWpGaD
Amoxapine—ADRA2A—Hemostasis—VEGFA—age related macular degeneration	0.000395	0.000395	CbGpPWpGaD
Amoxapine—DRD2—Signaling by GPCR—CCL2—age related macular degeneration	0.000395	0.000395	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—C3—age related macular degeneration	0.000395	0.000395	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—APOE—age related macular degeneration	0.00039	0.00039	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—C3—age related macular degeneration	0.000389	0.000389	CbGpPWpGaD
Amoxapine—HTR2A—Signaling by GPCR—CCL2—age related macular degeneration	0.000388	0.000388	CbGpPWpGaD
Amoxapine—HRH1—Signaling by GPCR—CCL2—age related macular degeneration	0.000388	0.000388	CbGpPWpGaD
Amoxapine—HRH4—Signaling Pathways—VEGFA—age related macular degeneration	0.000387	0.000387	CbGpPWpGaD
Amoxapine—CHRM1—Signaling by GPCR—CCL2—age related macular degeneration	0.000386	0.000386	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—KDR—age related macular degeneration	0.000382	0.000382	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling by GPCR—CCL2—age related macular degeneration	0.00038	0.00038	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—LIPC—age related macular degeneration	0.000378	0.000378	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—APOE—age related macular degeneration	0.000367	0.000367	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—CETP—age related macular degeneration	0.000365	0.000365	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—APOE—age related macular degeneration	0.000363	0.000363	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—KDR—age related macular degeneration	0.00036	0.00036	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—CCL2—age related macular degeneration	0.000359	0.000359	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—CCL2—age related macular degeneration	0.000358	0.000358	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—KDR—age related macular degeneration	0.000355	0.000355	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling by GPCR—CCL2—age related macular degeneration	0.000353	0.000353	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—CCL2—age related macular degeneration	0.000349	0.000349	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—CCL2—age related macular degeneration	0.000343	0.000343	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—C3—age related macular degeneration	0.000339	0.000339	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—C3—age related macular degeneration	0.000338	0.000338	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—CD36—age related macular degeneration	0.000337	0.000337	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—CCL2—age related macular degeneration	0.000328	0.000328	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—APOE—age related macular degeneration	0.000316	0.000316	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—APOE—age related macular degeneration	0.000314	0.000314	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—KDR—age related macular degeneration	0.00031	0.00031	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—CCL2—age related macular degeneration	0.000309	0.000309	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—KDR—age related macular degeneration	0.000308	0.000308	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—CCL2—age related macular degeneration	0.000305	0.000305	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—C3—age related macular degeneration	0.000298	0.000298	CbGpPWpGaD
Amoxapine—ADRA2A—Metabolism—APOE—age related macular degeneration	0.000297	0.000297	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—C3—age related macular degeneration	0.000293	0.000293	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—C3—age related macular degeneration	0.000293	0.000293	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—C3—age related macular degeneration	0.000292	0.000292	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—C3—age related macular degeneration	0.000287	0.000287	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—APOE—age related macular degeneration	0.000277	0.000277	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—APOE—age related macular degeneration	0.000273	0.000273	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—APOE—age related macular degeneration	0.000272	0.000272	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—KDR—age related macular degeneration	0.000272	0.000272	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—APOE—age related macular degeneration	0.000272	0.000272	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—KDR—age related macular degeneration	0.000267	0.000267	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—APOE—age related macular degeneration	0.000267	0.000267	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—KDR—age related macular degeneration	0.000267	0.000267	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—C3—age related macular degeneration	0.000267	0.000267	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—KDR—age related macular degeneration	0.000266	0.000266	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—CCL2—age related macular degeneration	0.000266	0.000266	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—CCL2—age related macular degeneration	0.000264	0.000264	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—KDR—age related macular degeneration	0.000262	0.000262	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—APOE—age related macular degeneration	0.000248	0.000248	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—KDR—age related macular degeneration	0.000243	0.000243	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—CCL2—age related macular degeneration	0.000233	0.000233	CbGpPWpGaD
Amoxapine—HTR6—Signaling Pathways—VEGFA—age related macular degeneration	0.00023	0.00023	CbGpPWpGaD
Amoxapine—HTR7—Signaling Pathways—VEGFA—age related macular degeneration	0.00023	0.00023	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—CCL2—age related macular degeneration	0.000229	0.000229	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—CCL2—age related macular degeneration	0.000229	0.000229	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—CCL2—age related macular degeneration	0.000228	0.000228	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—CCL2—age related macular degeneration	0.000225	0.000225	CbGpPWpGaD
Amoxapine—HTR1B—Signaling Pathways—VEGFA—age related macular degeneration	0.000224	0.000224	CbGpPWpGaD
Amoxapine—DRD4—Signaling Pathways—VEGFA—age related macular degeneration	0.00022	0.00022	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—CD36—age related macular degeneration	0.000219	0.000219	CbGpPWpGaD
Amoxapine—HTR2B—Signaling Pathways—VEGFA—age related macular degeneration	0.00021	0.00021	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—CCL2—age related macular degeneration	0.000209	0.000209	CbGpPWpGaD
Amoxapine—DRD1—Signaling Pathways—VEGFA—age related macular degeneration	0.000198	0.000198	CbGpPWpGaD
Amoxapine—DRD3—Signaling Pathways—VEGFA—age related macular degeneration	0.000196	0.000196	CbGpPWpGaD
Amoxapine—CYP2D6—Metabolism—APOE—age related macular degeneration	0.000194	0.000194	CbGpPWpGaD
Amoxapine—HTR1A—Signaling Pathways—VEGFA—age related macular degeneration	0.000171	0.000171	CbGpPWpGaD
Amoxapine—HTR2C—Signaling Pathways—VEGFA—age related macular degeneration	0.00017	0.00017	CbGpPWpGaD
Amoxapine—DRD2—Signaling Pathways—VEGFA—age related macular degeneration	0.00015	0.00015	CbGpPWpGaD
Amoxapine—HTR2A—Signaling Pathways—VEGFA—age related macular degeneration	0.000147	0.000147	CbGpPWpGaD
Amoxapine—HRH1—Signaling Pathways—VEGFA—age related macular degeneration	0.000147	0.000147	CbGpPWpGaD
Amoxapine—CHRM1—Signaling Pathways—VEGFA—age related macular degeneration	0.000147	0.000147	CbGpPWpGaD
Amoxapine—ADRA1A—Signaling Pathways—VEGFA—age related macular degeneration	0.000144	0.000144	CbGpPWpGaD
Amoxapine—ADRA2A—Signaling Pathways—VEGFA—age related macular degeneration	0.000134	0.000134	CbGpPWpGaD
